Clinical and Functional Characteristics of OSA in Children with Comorbid Asthma Treated by Leukotriene Receptor Antagonist: A Descriptive Study

Overview

Journal Front Neurol

Specialty Neurology

Date 2023 Jan 23

PMID 36686503

Authors

Sy Duong-Quy

Yen Nguyen-Hoang

Le Nguyen-Ngoc-Quynh

Mai Nguyen-Thi-Phuong

Hanh Nguyen-Thi-Bich

Huong Le-Thi-Minh

Thuy Nguyen-Thi-Dieu

Affiliations

Soon will be listed here.

Abstract

Background: Obstructive sleep apnea (OSA) is the most common form of respiratory disorders during sleep in children, especially those with severe asthma. However, optimal treatment of asthma might significantly improve OSA severity.

Methods: It was a cohort study including children aged >5 years old and diagnosed with asthma according to GINA (Global Initiative for Asthma). The data related to age, gender, height, weight, body mass index (BMI), clinical symptoms and medical history of asthma, spirometry (FEV: forced expiratory in 1 s), and exhaled nitric oxide (FNO) were recorded for analysis. Respiratory polygraphy (RPG) was done for each study subject to diagnose OSA and its severity.

Results: Among 139 asthmatic children, 99 patients with OSA (71.2%) were included in the present study (9.3 ± 0.2 years): 58.6% with uncontrolled asthma and 32.3% with partial controlled asthma. The mean ACT (asthma control testing) score was 19.0 ± 3.4. The most frequent night-time symptoms were restless sleep (76.8%), snoring (61.6%), sweating (52.5%), and trouble breathing during sleep (48.5%). The common daytime symptoms were irritable status (46.5%) and abnormal behavior (30.3%). The mean AHI (apnea-hypopnea index) was 3.5 ± 4.0 events/h. There was a significant correlation between BMI and snoring index ( = 0.189 and = 0.027), bronchial and nasal FNO with AHI ( = 0.046 and < 0.001; = 0.037 and < 0.001; respectively). There was no significant correlation between asthma level, FEV and AHI. The severity of asthma and respiratory function were improved significantly after 3 months and 6 months of asthma treatment in combination with leukotriene receptor antagonist (LRA) treatment. The symptoms related to OSA were significantly improved after treatment with LRA. The severity of OSA was decreased significantly after 3 months and 6 months of treatment.

Conclusion: The treatment of asthmatic children with comorbid OSA by LRA in combination with standard therapy for asthma could improve the control of asthma and the symptoms and severity of OSA.

References

Sanchez T, Castro-Rodriguez J, Brockmann P . Sleep-disordered breathing in children with asthma: a systematic review on the impact of treatment. J Asthma Allergy. 2016; 9:83-91. PMC: 4844256. DOI: 10.2147/JAA.S85624. View

Larsson L, Lindberg A, Franklin K, Lundback B . Symptoms related to obstructive sleep apnoea are common in subjects with asthma, chronic bronchitis and rhinitis in a general population. Respir Med. 2001; 95(5):423-9. DOI: 10.1053/rmed.2001.1054. View

Tran-Minh D, Phi-Thi-Quynh A, Nguyen-Dinh P, Duong-Quy S . Efficacy of obstructive sleep apnea treatment by antileukotriene receptor and surgery therapy in children with adenotonsillar hypertrophy: A descriptive and cohort study. Front Neurol. 2022; 13:1008310. PMC: 9552176. DOI: 10.3389/fneur.2022.1008310. View

Franklin K, Lindberg E . Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis. 2015; 7(8):1311-22. PMC: 4561280. DOI: 10.3978/j.issn.2072-1439.2015.06.11. View

Julien J, Martin J, Ernst P, Olivenstein R, Hamid Q, Lemiere C . Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol. 2009; 124(2):371-6. DOI: 10.1016/j.jaci.2009.05.016. View

Gilmartin G, Tamisier R, Curley M, Woodrow Weiss J . Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol. 2008; 295(2):H778-85. PMC: 2519226. DOI: 10.1152/ajpheart.00653.2007. View

Goldbart A, Greenberg-Dotan S, Tal A . Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics. 2012; 130(3):e575-80. DOI: 10.1542/peds.2012-0310. View

Teodorescu M, Polomis D, Hall S, Teodorescu M, Gangnon R, Peterson A . Association of obstructive sleep apnea risk with asthma control in adults. Chest. 2010; 138(3):543-50. PMC: 2940069. DOI: 10.1378/chest.09-3066. View

Kheirandish-Gozal L, Bandla H, Gozal D . Montelukast for Children with Obstructive Sleep Apnea: Results of a Double-Blind, Randomized, Placebo-Controlled Trial. Ann Am Thorac Soc. 2016; 13(10):1736-1741. PMC: 6944383. DOI: 10.1513/AnnalsATS.201606-432OC. View

10.

Anandi S, Tullu M, Lahiri K . Evaluation of symptoms & spirometry in children treated for asthma. Indian J Med Res. 2016; 144(1):124-127. PMC: 5116885. DOI: 10.4103/0971-5916.193299. View

11.

Lewis D . Sleep in patients with asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2001; 7(2):105-12. DOI: 10.1097/00063198-200103000-00008. View

12.

Li A, Au C, So H, Lau J, Ng P, Wing Y . Prevalence and risk factors of habitual snoring in primary school children. Chest. 2010; 138(3):519-27. DOI: 10.1378/chest.09-1926. View

13.

Gutierrez M, Zhu J, Rodriguez-Martinez C, Nino C, Nino G . Nocturnal phenotypical features of obstructive sleep apnea (OSA) in asthmatic children. Pediatr Pulmonol. 2012; 48(6):592-600. DOI: 10.1002/ppul.22713. View

14.

Vijverberg S, Hilvering B, Raaijmakers J, Lammers J, der Zee A, Koenderman L . Clinical utility of asthma biomarkers: from bench to bedside. Biologics. 2013; 7:199-210. PMC: 3762671. DOI: 10.2147/BTT.S29976. View

15.

Dang-Thi-Mai K, Le-Dong N, Le-Thuong V, Tran-Van N, Duong-Quy S . Exhaled Nitric Oxide as a Surrogate Marker for Obstructive Sleep Apnea Severity Grading: An In-Hospital Population Study. Nat Sci Sleep. 2021; 13:763-773. PMC: 8214111. DOI: 10.2147/NSS.S307012. View

16.

Marcus C, Brooks L, Draper K, Gozal D, Halbower A, Jones J . Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012; 130(3):e714-55. DOI: 10.1542/peds.2012-1672. View

17.

Hunter S, Gozal D, Smith D, Philby M, Kaylegian J, Kheirandish-Gozal L . Effect of Sleep-disordered Breathing Severity on Cognitive Performance Measures in a Large Community Cohort of Young School-aged Children. Am J Respir Crit Care Med. 2016; 194(6):739-47. PMC: 5027230. DOI: 10.1164/rccm.201510-2099OC. View

18.

Horwood L, Fergusson D, SHANNON F . Social and familial factors in the development of early childhood asthma. Pediatrics. 1985; 75(5):859-68. View

19.

Ngo-Minh X, Tang-Thi-Thao T, Doan-Thi-Quynh N, Craig T, Duong-Quy S . Study of the role of exhaled nitric oxide (NO) in predicting controlled or uncontrolled asthma in asthmatic children. Multidiscip Respir Med. 2020; 15(1):656. PMC: 7232017. DOI: 10.4081/mrm.2020.656. View

20.

Shigemitsu H, Afshar K . Nocturnal asthma. Curr Opin Pulm Med. 2006; 13(1):49-55. DOI: 10.1097/MCP.0b013e328010a890. View